108
Participants
Start Date
June 18, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
July 30, 2026
Hemophilia Center of Western Pennsylvania, Pittsburgh
Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania, Philadelphia
Children's Healthcare of Atlanta/Emory, Atlanta
University of Florida Hemophilia Treatment Center, Gainesville
Vanderbilt University Medical Center, Nashville
University of Tennessee, University Clinical Health (Memphis), Memphis
Nationwide Children's Hospital Columbus, Columbus
Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis
University of Michigan Hemophilia and Coagulation Disorders, Ann Arbor
Children's Hospital of Michigan Hemostasis and Thrombosis Center, Detroit
Michigan State University Center for Bleeding and Clotting Disorders, East Lansing
Versiti - Blood Center of Wisconsin, Milwaukee
Hemophilia Outreach Center, Green Bay
Mayo Comprehensive Hemophilia Center, Rochester
Bleeding and Clotting Disorders Institute, Peoria
Washington University Center for Treatment of Bleeding and Blood Clotting Disorders, St Louis
Louisiana Center for Bleeding and Clotting Disorders, New Orleans
University of Colorado Denver Hemophilia and Thrombosis Center, Aurora
Oregon Health, Portland
Center for Inherited Blood Disorders, Orange
Connecticut Bleeding and Clotting Disorders Center, Farmington
Rhode Island Hemostasis & Thrombosis Center, Providence
Collaborators (1)
Takeda
INDUSTRY
American Thrombosis and Hemostasis Network
NETWORK